Mabwell Says IND Application Acceptance For CDH17-Targeting ADC 7MW4911 From Both NMPA & FDA

RefinitivMeno di 1 minuto di lettura

Mabwell Shanghai Bioscience Co Ltd 688062:

MABWELL ANNOUNCES IND APPLICATION ACCEPTANCE FOR CDH17-TARGETING ADC 7MW4911 FROM BOTH NMPA AND FDA

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Accedi o crea un account gratuito per leggere queste notizie